Minimally invasive glaucoma surgery: current status and future prospects
Citations Over TimeTop 1% of 2016 papers
Abstract
Abstract: Minimally invasive glaucoma surgery aims to provide a medication-sparing, conjunctival-sparing, ab interno approach to intraocular pressure reduction for patients with mild-to-moderate glaucoma that is safer than traditional incisional glaucoma surgery. The current approaches include: increasing trabecular outflow (Trabectome, iStent, Hydrus stent, gonioscopy-assisted transluminal trabeculotomy, excimer laser trabeculotomy); suprachoroidal shunts (Cypass micro-stent); reducing aqueous production (endocyclophotocoagulation); and subconjunctival filtration (XEN gel stent). The data on each surgical procedure for each of these approaches are reviewed in this article, patient selection pearls learned to date are discussed, and expectations for the future are examined. Keywords: MIGS, microincisional glaucoma surgery, trabecular stent, Schlemm’s canal, suprachoroidal shunt, ab interno
Related Papers
- Screening for glaucoma in the Chinese elderly population in Singapore.(1999)
- Deletion/Deletion genotype of angiotensin-I converting enzyme gene is not associated with coronary artery disease in caucasians with type 2 diabetes.(2005)
- → Modern methods of visualization of the angle of the anterior chamber of the eye in the diagnosis and treatment of glaucoma(2022)1 cited
- → OCT Imaging of Schlemm’s Canal after Gonioscopy-Assisted Transluminal Trabeculotomy(2021)1 cited
- Emphasis on gonioscopy for glaucoma diagnosis and treatment(2010)